Pegaferon and Ribavirin for Hepatitis C
NCT01137383
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
108
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
Interventions
DRUG:
Pegaferon (pegylated interferon alpha 2a) + ribavirin
Sponsor
Tehran University of Medical Sciences
Collaborators
[object Object]